Table 3 Clinical outcomes of low dose HES vs moderate dose HES group
Variables | Low dose HES (n = 1239) | Moderate dose HES (n = 418) | p-value |
|---|---|---|---|
Acute kidney injury | 78 (6.3) | 45 (10.7) | .02 |
RIFLE (Risk) | 56 (4.5) | 34 (8.1) | |
RIFLE (Injury) | 18 (1.4) | 8 (1.9) | |
RIFLE (Failure) | 4 (0.3) | 3 (0.7) | |
KDIGO | 101 (8.2) | 57 (13.6) | .02 |
New renal replacement therapy | 40 (3.2) | 18 (4.3) | .30 |
ICU stay, days | 2.9 ± 7.7 | 2.9 ± 2.8 | .003 |
30-day mortality | 21 (1.6) | 7 (1.6) | .97 |
Mortality after 30-day | 37 (2.9) | 22 (5.2) | .03 |